http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007141768-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C277-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C277-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
| filingDate | 2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007141768-A |
| titleOfInvention | ORGANIC COMPOUNDS |
| abstract | 1. A pharmaceutically acceptable salt of the camostat, which is selected from the group consisting of camostat hydrosuccinate, camostat succinate, camostat acetate, camostat hydrotartrate, camostat glycolate, camostat hippurate, camostat 1-hydroxy-2-naphthoate camostat, adipate camostat camostat or their solvates. ! 2. The salt according to claim 1, which is selected from the group consisting of camostat hydrosuccinate, camostat succinate, camostat phosphate, camostat hemihydrate, camostat glycolate, camostat glycolate hemihydrate, camostat hippurate, camostat 1-hydroxy-2-naphthoate camostat (xoc ), adipate camostat and glutarate camostat. ! 3. The use of salt according to claim 1 or 2 to obtain a medicinal product intended for the treatment of cystic fibrosis or chronic obstructive pulmonary disease (COPD). ! 4. A method of producing a lyophilized dried form of a pharmaceutically acceptable salt of camostat, which comprises (1) obtaining an aqueous solution containing a salt of camostat and (2) lyophilizing the resulting aqueous solution. ! 5. The method according to claim 4, in which the aqueous solution contains an excipient that is selected from the group comprising lactose, mannitol and glucose. ! 6. The method according to claim 4 or 5, in which the salt of the camostat is camostat mesylate. ! 7. The method according to claim 4 or 5, wherein the camostat salt is selected from the group consisting of camostat hydrosuccinate, camostat succinate, camostat phosphate, camostat hydrotartrate, camostat glycolate, camostat hippurate, camostat 1-hydroxy-2-naphthoate camostat (xinafoate ), adipate camostat and glutarate camostat or their solvates. ! 8. A method of obtaining a composition for inhalation spray, containing |
| priorityDate | 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.